Trimethaphan camsylate Disease Interactions
There are 3 disease interactions with trimethaphan camsylate.
Trimethaphan (applies to trimethaphan camsylate) hypotension
Major Potential Hazard, High plausibility. Applicable conditions: Anemia, Dehydration, Shock, Asphyxia
The use of trimethaphan is contraindicated in patients with anemia, hypovolemia, shock, asphyxia, respiratory insufficiency or other conditions in which the vasodilating and hypotensive effects of trimethaphan may pose undue risk.
Trimethaphan (applies to trimethaphan camsylate) allergies
Moderate Potential Hazard, Moderate plausibility.
Trimethaphan causes histamine release. A histamine-like reaction has been observed along the vein used for drug administration. Although it is considered a weak histamine liberator, therapy with trimethaphan should be administered cautiously in patients with allergies.
Trimethaphan (applies to trimethaphan camsylate) reduced blood flow
Moderate Potential Hazard, High plausibility. Applicable conditions: Liver Disease, Cardiovascular Disease, Adrenal Insufficiency, Renal Dysfunction, Diabetes Mellitus
The use of trimethaphan may reduce coronary and cerebral blood flow. Therapy with trimethaphan should be administered cautiously in patients with arteriosclerosis, cardiac disease, hepatic or renal disease, degenerative CNS disease, Addison's disease, and diabetes. Monitoring heart rate and blood pressure at frequent intervals is recommended.
Switch to professional interaction data
Trimethaphan camsylate drug interactions
There are 184 drug interactions with trimethaphan camsylate.
Trimethaphan camsylate alcohol/food interactions
There is 1 alcohol/food interaction with trimethaphan camsylate.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.